FIELD: oncology.
SUBSTANCE: invention relates to a method of treating, preventing and/or reducing the intensity of radiation dermatitis caused by radiation therapy. The following is proposed: the use in a subject in need of a composition for external use containing a therapeutically or prophylactically effective amount of at least one BRaf inhibitor.
EFFECT: provides reduction in severity or prevention of worsening of radiation dermatitis.
16 cl, 6 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW BRAF INHIBITORS AND THEIR USE FOR TREATMENT OF SKIN REACTIONS | 2018 |
|
RU2779185C2 |
| PHARMACEUTICAL COMBINATIONS | 2017 |
|
RU2759669C2 |
| USING BRAF INHIBITORS FOR TREATING SKIN REACTIONS | 2017 |
|
RU2722667C2 |
| THERAPEUTIC COMBINATIONS CONTAINING RAF INHIBITOR AND ERK INHIBITOR | 2017 |
|
RU2774612C2 |
| DOSES OF PANOBINOSTAT FOR MULTIPLE MYELOMA | 2016 |
|
RU2729425C2 |
| COMBINATION THERAPY | 2018 |
|
RU2815400C2 |
| THERAPEUTIC USE OF OXIDATIVE HYPOTONIC ACID SOLUTIONS | 2020 |
|
RU2822544C2 |
| USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME | 2010 |
|
RU2543325C2 |
| THERAPEUTIC USE OF MEDICINAL FORMS OF BERBERINE | 2016 |
|
RU2733743C2 |
| METHODS OF TREATING DISEASES ASSOCIATED WITH S1P1 RECEPTOR | 2021 |
|
RU2821032C1 |
